Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma
- 1 September 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 4 (9), 1338-1348
- https://doi.org/10.1158/1535-7163.mct-05-0141
Abstract
The effect of methionine deprivation (methionine stress) on the proliferation, survival, resistance to chemotherapy, and regulation of gene and protein expression in pancreatic tumor lines is examined. Methionine stress prevents successful mitosis and promotes cell cycle arrest and accumulation of cells with multiple micronuclei with decondensed chromatin. Inhibition of mitosis correlates with CDK1 down-regulation and/or inhibition of its function by Tyr15 phosphorylation or Thr161 dephosphorylation. Inhibition of cell cycle progression correlates with loss of hyperphosphorylated Rb and up-regulation of p21 via p53 and/or transforming growth factor-β (TGF-β) activation depending on p53 status. Although methionine stress–induced toxicity is not solely dependent on p53, the gain in p21 and loss in CDK1 transcription are more enhanced in wild-type p53 tumors. Up-regulation of SMAD7, a TGF-β signaling inhibitor, suggests that SMAD7 does not restrict the TGF-β-mediated induction of p21, although it may prevent up-regulation of p27. cDNA oligoarray analysis indicated a pleiotropic response to methionine stress. Cell cycle and mitotic arrest is in agreement with up-regulation of NF2, ETS2, CLU, GADD45α, GADD45β, and GADD45γ and down-regulation of AURKB, TOP2A, CCNA, CCNB, PRC1, BUB1, NuSAP, IFI16, and BRCA1. Down-regulation of AREG, AGTR1, M-CSF, and EGF, IGF, and VEGF receptors and up-regulation of GNA11 and IGFBP4 signify loss of growth factor support. PIN1, FEN1, and cABL up-regulation and LMNB1, AREG, RhoB, CCNG, TYMS, F3, and MGMT down-regulation suggest that methionine stress sensitizes the tumor cells to DNA-alkylating drugs, 5-fluorouracil, and radiation. Increased sensitivity of pancreatic tumor cell lines to temozolomide is shown under methionine stress conditions and is attributed in part to diminished O6-methylguanine-DNA methyltransferase and possibly to inhibition of the cell cycle progression.Keywords
Other Versions
This publication has 40 references indexed in Scilit:
- Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplicationCell Death & Differentiation, 2005
- The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 ExpressionMolecular and Cellular Biology, 2005
- Bub1 Multitasking in MitosisCell Cycle, 2004
- CP-31398 Restores DNA-binding Activity to Mutant p53 in Vitro but Does Not Affect p53 Homologs p63 and p73Online Journal of Public Health Informatics, 2004
- Modulation of Gene Expression in Human Central Nervous System Tumors under Methionine Deprivation-induced StressCancer Research, 2004
- Cell cycle-dependent regulation of the human aurora B promoterBiochemical and Biophysical Research Communications, 2004
- The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insultsNature, 2002
- Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compoundNature Medicine, 2002
- Suppression of Keratinocyte Growth and Differentiation by Transforming Growth Factor β1 Involves Multiple Signaling PathwaysJournal of Investigative Dermatology, 2001
- Regional chemotherapy in the treatment of advanced pancreatic cancer — is it relevant?European Journal of Cancer, 2000